Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Endometrial Neoplasms and MDM2[original query] |
|---|
| Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. Gynecologic oncology 2007 Mar 104 (3): 660-4. Walsh Christine S, Miller Carl W, Karlan Beth Y, Koeffler H Phill |
| MDM2 SNP309 is associated with endometrial cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Apr 17 (4): 983-6. Terry Kathryn, McGrath Monica, Lee I-Min, Buring Julie, De Vivo Immacula |
| Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecologic oncology 2009 Apr 113 (1): 109-14. Ashton Katie A, Proietto Anthony, Otton Geoffrey, Symonds Ian, McEvoy Mark, Attia John, Gilbert Michael, Hamann Ute, Scott Rodney |
| Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer. Human cell 2009 Nov 22 (4): 101-6. Nunobiki Osamu, Ueda Masatsugu, Yamamoto Michiko, Toji Eisaku, Sato Naomi, Izuma Shinji, Okamoto Yoshiaki, Torii Kiyo, Noda Sada |
| MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis. Human cell : official journal of Human Cell Research Society 2011 Mar . Li Y, Zhao H, Sun L, Huang L, Yang Q, Kong B |
| SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. European journal of cancer (Oxford, England : 1990) 2011 Nov . Knappskog S, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Romundstad P, Hveem K, Vatten L, Salvesen HB, Lønning PE |
| MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. International journal of cancer. Journal international du cancer 2012 Dec 131 (11): 2710-6. Ryan Bríd M, Calhoun Kara M, Pine Sharon R, Bowman Elise D, Robles Ana I, Ambs Stefan, Harris Curtis |
| Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer. Oncology reports 2013 Jul 30 (1): 25-34. Yoneda Tomoko, Kuboyama Ayumi, Kato Kiyoko, Ohgami Tatsuhiro, Okamoto Kanako, Saito Toshiaki, Wake Nor |
| MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Nov . Wang LH, Wang X, Xu WT, Hu YL |
| Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women. Polish journal of pathology : official journal of the Polish Society of Pathologists 2012 Dec 63 (4): 4. Zaj?c A, Stachowiak G, Perty?ski T, Romanowicz H, Wilczy?ski J, Smolarz B |
| Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Aug 35 (8): 7555-60. Zhao Yan, Yang Xiaoer, Hao Xiaojiao, Pan Xiaolin, Zhao Bo, Ma Jingwen, Fang Jian, Zhao Mingho |
| MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case-control study. Infectious agents and cancer 2014 9 (1): 11. Rebbani Khadija, Ezzikouri Sayeh, Marchio Agnès, Kandil Mostafa, Pineau Pascal, Benjelloun Souma |
| Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649). Oncotarget 2014 Sep 5 (18): 8223-34. Knappskog Stian, Gansmo Liv B, Dibirova Khadizha, Metspalu Andres, Cybulski Cezary, Peterlongo Paolo, Aaltonen Lauri, Vatten Lars, Romundstad Pål, Hveem Kristian, Devilee Peter, Evans Gareth D, Lin Dongxin, Van Camp Guy, Manolopoulos Vangelis G, Osorio Ana, Milani Lili, Ozcelik Tayfun, Zalloua Pierre, Mouzaya Francis, Bliznetz Elena, Balanovska Elena, Pocheshkova Elvira, Ku?inskas Vaidutis, Atramentova Lubov, Nymadawa Pagbajabyn, Titov Konstantin, Lavryashina Maria, Yusupov Yuldash, Bogdanova Natalia, Koshel Sergey, Zamora Jorge, Wedge David C, Charlesworth Deborah, Dörk Thilo, Balanovsky Oleg, Lønning Per |
| TP53 and MDM2 polymorphisms and the risk of endometrial cancer in postmenopausal women. Medical oncology (Northwood, London, England) 2014 Nov 31 (11): 286. Zaj?c Agnieszka, Smolarz Beata, Stachowiak Grzegorz, Wilczy?ski Jacek |
| MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis. Journal of experimental & clinical cancer research : CR 2013 32 (1): 85. Peng Qiliu, Mo Cuiju, Qin Aiping, Lao Xianjun, Chen Zhiping, Sui Jingzhe, Wu Junrong, Zhai Limin, Yang Shi, Qin Xue, Li Sh |
| SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers. BMC medical genetics 2015 16 (1): 67. Okamoto Kanako, Tsunematsu Ryosuke, Tahira Tomoko, Sonoda Kenzo, Asanoma Kazuo, Yagi Hiroshi, Yoneda Tomoko, Hayashi Kenshi, Wake Norio, Kato Kiyo |
| Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis. Medical science monitor : international medical journal of experimental and clinical research 2016 22 3186-90. Xue Zhuowei, Zhu Xiaolu, Teng Yinche |
| The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Feb . Gansmo Liv B, Bjørnslett Merete, Halle Mari Kyllesø, Salvesen Helga B, Dørum Anne, Birkeland Einar, Hveem Kristian, Romundstad Pål, Vatten Lars, Lønning Per Eystein, Knappskog Sti |
| MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk. BMC cancer 2017 Feb 17 (1): 97. Gansmo Liv B, Bjørnslett Merete, Halle Mari Kyllesø, Salvesen Helga B, Romundstad Pål, Hveem Kristian, Vatten Lars, Dørum Anne, Lønning Per E, Knappskog Sti |
| The association between murine double minute 2 (MDM2) rs2279744 and endometrial cancer risk in a Chinese Han population. Cellular and molecular biology (Noisy-le-Grand, France) 2017 Oct 63 (10): 128-130. Wu J-P, Luo |
| Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis. Medicine 2018 Dec 97 (49): e13273. Zou Xinwei, Zhang Yi, Zhang Lin, Li Jiaxi, Zhu Chenjie, Cheng Qiuhong, Zhou Jinhua, Chen Youg |
| Impact of MDM2, TP53 and P14ARF Polymorphisms on Endometrial Cancer Risk and Onset. In vivo (Athens, Greece) 0 33 (3): 917-924. Wujcicka Wioletta, Zaj?c Agnieszka, Stachowiak Grzego |
| Association between genetic polymorphisms and endometrial cancer risk: a systematic review. Journal of medical genetics 2020 Feb . Bafligil Cemsel, Thompson Deborah J, Lophatananon Artitaya, Smith Miriam J, Ryan Neil Aj, Naqvi Anie, Evans D Gareth, Crosbie Emma |
| Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2021 Feb 1-7. Helwa Reham, Gansmo Liv B, Bjørnslett Merete, Halle Mari Kyllesø, Werner Henrica M J, Romundstad Pål, Hveem Kristian, Vatten Lars, Dørum Anne, Lønning Per E, Knappskog Sti |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: